How Investors Are Leveraging Mindgram for Smarter Research and Portfolio Management

Staying well informed within drugs and therapeutic areas of interest is critical for healthcare investors. That’s why investors are using Mindgram to leverage AI for portfolio monitoring.

Tracking developments across news, scientific publications, patents, FDA events, earnings, and financial documents can be overwhelming. Mindgram automates this process, providing a comprehensive view of relevant data. Its Watchlist and AI-powered Summary Digest feature summarizes information around drugs, companies, and/or indications into professional-grade reports, easily shared with internal teams, and can be filtered to certain time periods. ‍

Watch how investors are using Mindgram’s Watchlist and Summary Digest feature to monitor companies and drugs of interest:
‍